文献速递癫痫

癫痫辅助犬对严重难治性癫痫患者的有效性:EPISODE研究结果

Effectiveness of Seizure Dogs for People With Severe Refractory Epilepsy: Results From the EPISODE Study.
PubMed 文献 · Neurology · 2024-02-28

EPISODE研究为个体水平阶梯楔形随机对照试验,在荷兰纳入25例每日至每周发作的成人严重难治性癫痫患者,随机顺序接受癫痫辅助犬。结果显示,干预条件下每28天发作频率降低3.1%(0.969,95%CI 0.960-0.977),无发作天数增加(1.012,95%CI 1.009-1.015),EQ-5D-5L效用值改善(0.975,95%CI 0.954-0.997),但NHS3评估的发作严重程度无影响。

要点

  • 癫痫辅助犬与成人难治性癫痫患者发作频率降低相关。
  • 干预期间每28天发作频率降低3.1%(0.969,95%CI 0.960-0.977)。
  • 无发作天数增加(1.012,95%CI 1.009-1.015),通用生活质量改善(0.975,95%CI 0.954-0.997)。

主要发现

  • 25例参与者中20例交叉至干预条件,常规照护中位随访19个月,干预中位随访12个月。
  • 常规照护条件下每28天平均发作115次(SD 164),干预条件下平均发作73次(SD 131)。
  • 7例参与者在随访结束时发作减少≥50%。
  • 广义线性混合模型显示,干预每连续28天发作频率降低3.1%(0.969,95%CI 0.960-0.977),无发作天数增加(1.012,95%CI 1.009-1.015)。
  • EQ-5D-5L效用值递减减少(0.975,95%CI 0.954-0.997),EQ VAS、QOLIE-31-P和ICECAP-A分别显示整体自评健康相关生活质量、癫痫特异性健康相关生活质量和幸福感有较小改善;NHS3评估的发作严重程度无影响。

关键数值与推荐

  • 每连续28天干预期间发作频率降低3.1%(0.969,95%CI 0.960-0.977)。
  • 无发作天数增加(1.012,95%CI 1.009-1.015)。
  • EQ-5D-5L效用值递减减少(0.975,95%CI 0.954-0.997)。
  • NHS3评估的发作严重程度无影响。
  • 7例参与者在随访结束时发作减少≥50%。

临床怎么用

  • 作者认为癫痫辅助犬可降低严重难治性癫痫患者的发作频率、增加无发作天数并改善生活质量。
  • 作者指出癫痫辅助犬合作关系的早期终止提示该干预并非适合所有严重难治性癫痫患者,需进一步研究。

局限性

  • 早期终止癫痫辅助犬合作关系提示该干预并非适合所有严重难治性癫痫患者,需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: The aim of this study was to evaluate whether people living with severe medically refractory epilepsy (PSRE) benefit from a seizure dog. METHODS: An individual-level stepped-wedge randomized controlled trial was conducted. The study was conducted in the Netherlands among adults with daily to weekly seizures. All participants were included simultaneously (on June 1, 2019) while receiving usual care. Then, during the 36-month follow-up, they received a seizure dog in a randomized sequence. Participants kept a seizure diary and completed 3-monthly surveys. Seizure frequency was the primary outcome. Secondary outcomes included seizure-free days, seizure severity, health-related quality of life (HRQoL), and well-being. Data were analyzed using generalized linear mixed modeling (GLMM). The models assumed a delayed intervention effect, starting when the seizure dog reached an advanced stage of training. Effects were calculated as changes per 28-day period with the intervention. RESULTS: Data were collected from 25 participants, of whom 20 crossed over to the intervention condition. The median follow-up was 19 months with usual care and 12 months with the intervention. On average, participants experienced 115 (SD 164) seizures per 28-day period in the usual care condition and 73 (SD 131) seizures in the intervention condition. Seven participants achieved a reduction of 50% or more at the end of follow-up. GLMM indicated a 3.1% decrease in seizure frequency for each consecutive 28-day period with the intervention (0.969, 95% CI 0.960-0.977). Furthermore, an increase in the number of seizure-free days was observed (1.012, 95% CI 1.009, 1.015), but no effect on seizure severity measured with the NHS3. Generic HRQoL scores improved, as reflected in the decrease in EQ-5D-5L utility decrement (0.975, 95% CI 0.954-0.997). Smaller improvements were observed on overall self-rated HRQoL, epilepsy-specific HRQoL, and well-being, measured with the EQ VAS, QOLIE-31-P, and ICECAP-A, respectively. DISCUSSION: Seizure dogs reduce seizure frequency, increase the number of seizure-free days, and improve the quality of life of PSRE. The magnitude of the effect on generic HRQoL indicates that seizure dogs benefit PSRE beyond the impact on seizure frequency alone. Early discontinuation of seizure dog partnerships suggests that this intervention is not suitable for all PSRE and requires further study. TRIAL REGISTRATION INFORMATION: This study was registered in the Dutch Trial Register (NL6682) on November 28, 2017. Participants were enrolled on June 1, 2019. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that seizure dogs are associated with a decrease in seizure frequency in adult patients with medically refractory epilepsy.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. van Hezik-Wester V, de Groot S, Kanters T, et al. Effectiveness of Seizure Dogs for People With Severe Refractory Epilepsy: Results From the EPISODE Study. Neurology. 2024. PMID: 38417090. doi:10.1212/WNL.0000000000209178

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。